News

EXCLUSIVE: MIRA Pharmaceuticals Ketamir-2 Shows Efficacy In Diabetes-Associated Nerve Damage In Animal Study
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) on Wednesday released data demonstrating the efficacy of the oral ketamine analog, ...
Mira Pharmaceuticals announces results for Ketamir-2 in diabetic neuropathy
MIRA Pharmaceuticals (MIRA) announced data demonstrating the efficacy of the oral ketamine analog, Ketamir-2, in a validated animal model of ...
MIRA Pharmaceuticals Announces Positive Results for Ketamir-2 in Diabetic Neuropathy Animal Model, Reinforcing Confidence Ahead of Phase I Completion
Ketamir-2 Demonstrates Strong Efficacy in Diabetic Neuropathy Model, with Some Subjects Achieving Complete Symptom Reversal MIAMI, FLORIDA / ACCESS Newswire / April 16, 2025 / MIRA Pharmaceuticals, ...
All Penny Stocks (English) on MSN9h
Pharmaceutical Stock Jumps After Key Trial Findings
Real-time index price for S&P 500 Energy [Sector] (SREN), along with buy or sell indicators, analysis, charts, historical ...
Irish Examiner on MSN14h
Opioid addiction three times higher in Dublin than the rest of Ireland, new study finds
The number of people with problematic use of opioids like heroin is three times higher in Dublin than the rest of Ireland, ...